Search

for
Search:

Glossary Cetuximab

monoclonal antibody used to treat certain cancers by targeting EGFR

Cetuximab, also known by the brand name Erbitux, is a monoclonal antibody used in cancer treatment. It works by targeting the epidermal growth factor receptor (EGFR) on the surface of cancer cells, inhibiting their growth and survival. This drug is commonly used to treat certain types of head, neck, and colorectal cancers.

Related Terms

Research

5 / 225 results

research Trichomegaly of the eyelashes following treatment with cetuximab

78 citations , June 2005 in “Annals of oncology”

This case study reported that a 74-year-old woman with metastatic rectal cancer experienced temporary trichomegaly, or eyelash lengthening, associated with cetuximab treatment, which resolved after discontinuation of the drug.

research Efficacy and Skin Toxicity Management with Cetuximab in Metastatic Colorectal Cancer: Outcomes from an Oncologic/Dermatologic Cooperation

42 citations , January 2008 in “Clinical colorectal cancer”

In this study, a combination of irinotecan and cetuximab showed varied response rates in metastatic colorectal cancer patients, with manageable skin toxicity that improved quality of life when treated collaboratively by oncology and dermatology teams.